Ritobroto Maitra

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Age Related Macular Degeneration

Top Venues

Clinical ophthalmology (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Debdulal Chakraborty, Subhendu Boral, Tushar Kanti Sinha, Arnab Das, Angshuman Mukherjee, Saptorshi Majumdar, Ranabir Bhattacharya, Ritobroto Maitra
Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study. Clinical ophthalmology (Auckland, N.Z.) 18 (2024)
Debdulal Chakraborty, Subhendu Boral, Tushar Kanti Sinha, Arnab Das, Angshuman Mukherjee, Saptorshi Majumdar, Ranabir Bhattacharya, Ritobroto Maitra
Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study. Clinical ophthalmology (Auckland, N.Z.) 18 (2024)
Debdulal Chakraborty, Soumen Mondal, Subhendu Boral, Arnab Das, Tushar Kanti Sinha, Saptorshi Majumdar, Ranabir Bhattacharya, Ritobroto Maitra
Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)